Evidence map›Paper›PMID 31425507›Full record

ArticlePLoS neglected tropical diseases2019

Vaccination coverage in the context of the emerging Yellow Fever threat in French Guiana.

Claude Flamand, Sarah Bailly, Camille Fritzell, Sandrine Fernandes Pellerin, Alhassane Toure, Naïssa Chateau, Mona Saout, Sébastien Linares, Fabien Dubois, Laurent Filleul and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Do socioeconomic factors driveOne health (Amsterdam, Netherlands) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Claude FlamandEpidemiology Unit, Institut Pasteur in French Guiana, Cayenne, French Guiana.ORCID 0000-0002-8064-445X
Sarah BaillyEpidemiology Unit, Institut Pasteur in French Guiana, Cayenne, French Guiana.
Camille FritzellEpidemiology Unit, Institut Pasteur in French Guiana, Cayenne, French Guiana.
Sandrine Fernandes PellerinClinical Coordination of Translational Research Center, Institut Pasteur, Paris, France.
Alhassane ToureEpidemiology Unit, Institut Pasteur in French Guiana, Cayenne, French Guiana.
Naïssa ChateauEpidemiology Unit, Institut Pasteur in French Guiana, Cayenne, French Guiana.
Mona SaoutEpidemiology Unit, Institut Pasteur in French Guiana, Cayenne, French Guiana.
Sébastien LinaresGeographic Information and Knowledge Dissemination Unit, Direction de l'Environnement, de l'Aménagement et du logement Guyane, Cayenne, French Guiana.
Fabien DuboisGeographic Information and Knowledge Dissemination Unit, Direction de l'Environnement, de l'Aménagement et du logement Guyane, Cayenne, French Guiana.
Laurent FilleulFrench Public Health Agency, Paris, France.
Mirdad KazanjiEpidemiology Unit, Institut Pasteur in French Guiana, Cayenne, French Guiana.
University of French Guiana · GFInstitut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFrench Guiana, a French overseas department located in South America between Brazil and Surinam, is the only European territory geographically located in the Amazonian forest complex and is considered endemic for yellow fever (YF). In the context of the emergent threat of YF in Latin America, we conducted a large household cross-sectional survey from June to October 2017 to estimate vaccination coverage in the population and to determine associations with sociodemographic and geographical characteristics. METHODOLOGY/PRINCIPAL

findingsIn total, 1,415 households and 2,697 individuals were included from the 22 municipalities of French Guiana. YF vaccination coverage was estimated at 95.0% (95% CI: 93.4-96.2) in the entire territory but was spatially heterogeneous, with the lowest levels estimated in the western part of the territory along the Surinamese cross-border region, particularly in children under 16 years who were not enrolled in school, immigrant adults and disadvantaged populations with low socioeconomic indexes. CONCLUSIONS/SIGNIFICANCE: Despite the good vaccination coverage against YF in the general population of French Guiana resulting from the compulsory nature of YF vaccination for residents and travelers, there is an urgent need to improve vaccination coverage in vulnerable populations living in the northwestern part of the territory to limit the risk of transmission in the context of the emerging YF threat in South America. Despite the relative rarity of YF and the significant number of infectious and tropical diseases in French Guiana, clinicians should adopt a high index of suspicion for YF, particularly in vulnerable and at-risk populations.

Indexed as

AdolescentAdultAgedChildChild, PreschoolCross-Sectional StudiesDemographyDisease Transmission, InfectiousFamily CharacteristicsFemaleFrench GuianaHumansMaleMiddle AgedSocioeconomic FactorsVaccination CoverageYellow Fever Vaccine

Identifiers

PMID31425507
PMCPMC6715233
OpenAlexW2969365297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.